Search Press releases Keywords From To 23 Mar 2005 UCB Group confirms its previously announced 2004 results and provides IFRS reconciliation and product update Read More 1 Mar 2005 UCB: Closing Of The Sale Of Its Surface Specialties Division Read More 17 Feb 2005 FDA grants priority review to levetiracetam for use in childhood epilepsy Read More 7 Feb 2005 UCB Group preliminary full-year 2004 results Read More 25 Jan 2005 UCB Pharma enters into agreement to collaborate on two Biotherapeutic Inflammation Programs with Millennium Read More 19 Jan 2005 UCB Confirms Annual Zyrtec Sales In The US - Xyzal Sells More Than Zyrtec In Europe Read More Pagination First page Previous page Previous … Page 192 Page 193 Page 194 Page 195 Current page 196 Page 197 Page 198 Page 199 Page 200 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
